AR and neoplasm: In addition to its analysis in prostate cancer, AR expression has been analyzed in other tumors, such as bladder [12], breast [13], pancreas [14], liver [15] and ovary [16] tumors, providing additional information about tumor growth, survival time (liver, bladder [12]) and improvements for antiandrogen therapy (breast [17]).